Common Contracts
4 similar Asset Purchase Agreement contracts by Cancer Genetics, Inc, Response Genetics Inc
ContractAsset Purchase Agreement • May 5th, 2020 • Delaware
Execution Version AMENDED AND RESTATED ASSET PURCHASE AGREEMENT BY AND BETWEEN RESPONSE GENETICS, INC., A DELAWARE CORPORATION AND CANCER GENETICS, INC., A DELAWARE CORPORATION DATED AS OF AUGUST 14, 2015 Execution Version Table of Contents Page 1. Purchase and Sale........................................................................................................ 2 1.1 Assets to Be Transferred...................................................................................... 2 1.2 Excluded Assets................................................................................................... 3 1.3 Liabilities............................................................................................................. 5 1.4 Purchase Price; Deposit; and Allocation of Purchase Price................................. 7 1.5 Closing................................................................................................................. 9 1.6 Closing Deliveries by Seller......
AMENDED AND RESTATED ASSET PURCHASE AGREEMENT BY AND BETWEEN RESPONSE GENETICS, INC., A DELAWARE CORPORATION AND CANCER GENETICS, INC., A DELAWARE CORPORATION DATED AS OF AUGUST 14, 2015Asset Purchase Agreement • August 21st, 2015 • Cancer Genetics, Inc • Services-medical laboratories • Delaware
Real Property Leases Schedule 1.1(a) Contracts Schedule 1.1(b) Included Pharma Receivables Schedule 1.1(f) Included Avoidance Actions Schedule 1.1(o) Excluded Assets Schedule 1.2 Unpaid Sick Pay, Vacation and Other Paid Time Off Schedule 1.3(a)(ii) Conduct of Business Schedule 4.1(b) Access to Information (Employees - Supervised) Schedule 4.3(1) Access to Information (Employees - Unsupervised) Schedule 4.3(1) Transfer Employee Credit Schedule 4.6(b) Access to Personnel Schedule 4.8
ASSET PURCHASE AGREEMENT BY AND BETWEENAsset Purchase Agreement • August 11th, 2015 • Response Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
ASSET PURCHASE AGREEMENT (the “Agreement”), dated as of August 9, 2015 (the “Effective Date”), by and among Response Genetics, Inc., a Delaware corporation (the “Seller”), and Cancer Genetics, Inc., a Delaware corporation (the “Purchaser”). Capitalized terms used herein but not defined in the provisions in which they first appear shall have the meanings ascribed to them in Section 8.1(a) hereof.
ASSET PURCHASE AGREEMENT BY AND BETWEEN RESPONSE GENETICS, INC., A DELAWARE CORPORATION AND CANCER GENETICS, INC., A DELAWARE CORPORATION DATED AS OF AUGUST 9, 2015Asset Purchase Agreement • August 10th, 2015 • Cancer Genetics, Inc • Services-medical laboratories • Delaware
Real Property Leases Schedule 1.1(a) Contracts Schedule 1.1(b) Included Pharma Receivables Schedule 1.1(f) Included Avoidance Actions Schedule 1.1(o) Excluded Assets Schedule 1.2 Conduct of Business Schedule 4.1(b) Access to Personnel Schedule 4.8
